Lobbying

Terumo Blood and Cell Technologies's latest lobbying report covers Q1 2025, at under $5,000. Its first report covers Q4 2023; the issues it reports most are Health Issues.

Terumo Blood and Cell Technologies

Latest quarter
No record
Q2 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q2 2026 against the quarter before
First report
Q4 2023
The first quarter a report named it

Lobbying by quarter

Terumo Blood and Cell Technologies lobbying by quarter
Terumo Blood and Cell Technologies lobbying by quarter
QuarterAmountReports
Q4 2023$10K1
Q1 2024$10K1
Q2 2024$10K1
Q3 2024$10K1
Q4 2024$10K1
Q1 2025$01
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00

Policy issues the reports name

  • Health issues5 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE1 reports

Firms it paid

Firm
Becker & Poliakoff, P.A.$50K6 quarters

Former officials lobbying for it

Former position
CLARENCE WILLIAMSChief of Staff for Congressman Kendrick B. MeekQ4 2024

Lobbying reports

Filed by
25/04/18for Q1 2025Becker & Poliakoff, P.A.Under $5,000
25/01/19for Q4 2024Becker & Poliakoff, P.A.$10K
24/10/16for Q3 2024Becker & Poliakoff, P.A.$10K
24/07/16for Q2 2024Becker & Poliakoff, P.A.$10K
24/04/16for Q1 2024Becker & Poliakoff, P.A.$10K
24/01/22for Q4 2023Becker & Poliakoff, P.A.$10K
24/01/19for Q4 2023Becker & Poliakoff, P.A.$10K
23/11/13for Q4 2023Becker & Poliakoff, P.A.Under $5,000